Urology
 |
|
23 september 2019 23:00:05 |
| Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer (European Urology Oncology) |
|
Tweet In patients with metastatic castration-refractory prostate cancer, treatment with progression-directed therapy may result in substantial postponement of next-line systemic therapy, at a nearly negligible toxicity rate. Prospective trials are needed to endorse this finding. |
| 220 viewsCategory: Oncology, Urology |
 Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators (European Urology Oncology)Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma (European Urology Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page